标题
Real-world efficacy of galcanezumab for the treatment of migraine in Korean patients
作者
关键词
-
出版物
CEPHALALGIA
Volume -, Issue -, Pages 033310242210764
出版商
SAGE Publications
发表日期
2022-03-18
DOI
10.1177/03331024221076481
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Partial and nonresponders to onabotulinumtoxinA can benefit from anti‐CGRP monoclonal antibodies preventive treatment: A real‐world evidence study
- (2021) Alicia Alpuente et al. EUROPEAN JOURNAL OF NEUROLOGY
- Long‐term efficacy and safety during open‐label erenumab treatment in Japanese patients with episodic migraine
- (2021) Fumihiko Sakai et al. HEADACHE
- Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
- (2021) Fabrizio Vernieri et al. JOURNAL OF HEADACHE AND PAIN
- The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
- (2021) Marta Torres-Ferrús et al. JOURNAL OF NEUROLOGY
- Guidelines for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults
- (2020) Hans-Christoph Diener et al. CEPHALALGIA
- Safety and efficacy of galcanezumab in Taiwanese patients: a post-hoc analysis of phase 3 studies in episodic and chronic migraine
- (2020) Chun-Pai Yang et al. CURRENT MEDICAL RESEARCH AND OPINION
- Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial
- (2020) Wim M Mulleners et al. LANCET NEUROLOGY
- Erenumab efficacy in chronic migraine and medication overuse: a real-life multicentric Italian observational study
- (2020) Francesca Schiano di Cola et al. NEUROLOGICAL SCIENCES
- Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2
- (2020) Hans‐Christoph Diener et al. HEADACHE
- Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats
- (2019) Kirk W Johnson et al. CEPHALALGIA
- Erenumab in chronic migraine with medication overuse
- (2019) Stewart J. Tepper et al. NEUROLOGY
- Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
- (2019) Michel D Ferrari et al. LANCET
- Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier
- (2019) Rodrigo Noseda et al. CEPHALALGIA
- Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials
- (2019) D. D. Ruff et al. EUROPEAN JOURNAL OF NEUROLOGY
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
- (2018) Cristina Tassorelli et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
- (2018) Uwe Reuter et al. LANCET
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine
- (2015) Jong-Geun Seo et al. JOURNAL OF HEADACHE AND PAIN
- Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine
- (2015) Jong-Geun Seo et al. JOURNAL OF HEADACHE AND PAIN
- Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT
- (2014) Stephen D Silberstein et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine
- (2010) Min Yang et al. CEPHALALGIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started